,trial_id,completion_date_india,completion_date_global,recruitment_status_india,recruitment_status_global,publication_details,secondary_ids
0,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
1,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
2,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
3,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
4,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
5,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
6,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
7,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
8,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
9,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
10,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
11,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
12,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
13,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
14,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
15,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
16,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
17,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
18,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
19,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
20,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
21,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
22,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
23,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
24,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
25,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
26,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
27,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
28,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
29,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
30,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
31,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
32,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
33,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
34,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
35,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
36,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
37,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
38,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
39,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
40,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
41,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
42,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
43,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
44,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
45,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
